{"database": "lobbying", "table": "lobbying_activities", "rows": [[2821383, "0a079f2e-ab67-41fe-8601-e82898a42895", "Q2", "TIBER CREEK GROUP", 20744, "TIBER CREEK HEALTH STRATEGIES, INC. (ON BEHALF OF ELI LILLY AND COMPANY)", 2022, "second_quarter", "CPT", "H.R. 2891 - Preserve Access to Affordable Generics and Biosimilars Act.", "HOUSE OF REPRESENTATIVES,SENATE", 70000, null, 0, 0, "2022-07-15T19:29:16-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["2821383"], "units": {}, "query_ms": 0.618400052189827, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}